|
Form S-1
|
|
|
(Form Type)
|
|
|
CHEMOMAB THERAPEUTICS LTD.
|
|
|
(Exact Name of Registrant as Specified in its Charter)
|
|
Security
Type |
Security
Class Title |
Fee
Calculation or Carry Forward Rule |
Maximum
Aggregate Offering Price(1)(2) |
Fee
Rate |
Amount of
Registration Fee |
|||||||||||||
Newly Registered Securities
|
||||||||||||||||||
Fees to be Paid
|
Equity
|
Units consisting of (i) either one American Depositary Share or one Pre-Funded Warrant to purchase one American Depositary Share
and (ii) one Warrant to Purchase one American Depositary Share (2)(3)
|
(1
|
)
|
$
|
11,500,000.00
|
$
|
.0001102
|
$
|
1,267.30
|
||||||||
Fees to be Paid
|
Equity
|
American Depositary Shares issuable upon exercise of Pre-Funded Warrants and Warrants (2)
|
(1
|
)
|
$
|
11,500,000.00
|
$
|
.0001102
|
$
|
1,267.30
|
||||||||
Total Offering Amounts
|
$
|
23,000,000.00
|
$
|
2,534.60
|
||||||||||||||
Total Fees Previously Paid
|
$
|
3,306.00
|
||||||||||||||||
Total Fee Offsets
|
-
|
|||||||||||||||||
Net Fee Due
|
$
|
0.00
|
|
(1)
|
Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities
Act of 1933, as amended.
|
|
|
|
|
(2)
|
Each ADS represents twenty (20) ordinary shares of the registrant. ADSs issuable upon deposit of the ordinary shares registered
hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-229522).
|
|
|
|
|
(3)
|
Calculated in accordance with Rule 457(g) under the Securities Act, because the ADSs of the registrant underlying the warrants are
registered hereby.
|